Ferrosa Therapeutics is a Swiss biotechnology company founded in 2026 in Basel by Forty51 Ventures.
Ferrosa Therapeutics has raised $3.5M in total funding. The most recent round was Seed. The last funding was announced in April 2026.
Ferrosa Therapeutics's investors include Forty51 Ventures.
Ferrosa Therapeutics is headquartered in Basel, Switzerland.
Ferrosa Therapeutics is a Swiss biotechnology company founded in 2026 in Basel by Forty51 Ventures.
Ferrosa Therapeutics is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Ferrosa Therapeutics — Funding & Investors." VCBacked, April 23, 2026, https://www.vcbacked.co/company/ferrosa-therapeutics. Accessed August 1, 2026.
VCBacked. (2026). Ferrosa Therapeutics — Funding & Investors. Retrieved August 1, 2026, from https://www.vcbacked.co/company/ferrosa-therapeutics
{{cite web |title=Ferrosa Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/ferrosa-therapeutics |website=VCBacked |access-date=August 1, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated